nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—schizophrenia	0.778	1	CbGaD
Rasagiline—CYP1A2—urine—schizophrenia	0.00651	0.0983	CbGeAlD
Rasagiline—BCL2—forebrain—schizophrenia	0.00628	0.0948	CbGeAlD
Rasagiline—BCL2—telencephalon—schizophrenia	0.00578	0.0872	CbGeAlD
Rasagiline—BCL2—gonad—schizophrenia	0.00482	0.0728	CbGeAlD
Rasagiline—MAOB—blood plasma—schizophrenia	0.00477	0.0721	CbGeAlD
Rasagiline—BCL2—blood—schizophrenia	0.0042	0.0634	CbGeAlD
Rasagiline—BCL2—endocrine gland—schizophrenia	0.00364	0.055	CbGeAlD
Rasagiline—BCL2—nervous system—schizophrenia	0.00341	0.0515	CbGeAlD
Rasagiline—CYP1A2—blood plasma—schizophrenia	0.0034	0.0513	CbGeAlD
Rasagiline—BCL2—central nervous system—schizophrenia	0.00328	0.0496	CbGeAlD
Rasagiline—MAOB—forebrain—schizophrenia	0.00262	0.0395	CbGeAlD
Rasagiline—BCL2—brain—schizophrenia	0.00261	0.0393	CbGeAlD
Rasagiline—MAOB—telencephalon—schizophrenia	0.00241	0.0363	CbGeAlD
Rasagiline—MAOB—blood—schizophrenia	0.00175	0.0264	CbGeAlD
Rasagiline—MAOB—midbrain—schizophrenia	0.00173	0.0261	CbGeAlD
Rasagiline—MAOB—endocrine gland—schizophrenia	0.00152	0.0229	CbGeAlD
Rasagiline—MAOB—nervous system—schizophrenia	0.00142	0.0214	CbGeAlD
Rasagiline—MAOB—central nervous system—schizophrenia	0.00137	0.0206	CbGeAlD
Rasagiline—MAOB—cerebellum—schizophrenia	0.00134	0.0202	CbGeAlD
Rasagiline—CYP1A2—blood—schizophrenia	0.00125	0.0188	CbGeAlD
Rasagiline—MAOB—brain—schizophrenia	0.00109	0.0164	CbGeAlD
Rasagiline—CYP1A2—endocrine gland—schizophrenia	0.00108	0.0163	CbGeAlD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000936	0.00601	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP26B1—schizophrenia	0.00092	0.00591	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PAK6—schizophrenia	0.000866	0.00556	CbGpPWpGaD
Rasagiline—CYP1A2—Methylation—COMT—schizophrenia	0.000849	0.00545	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.000846	0.00543	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—HSPA8—schizophrenia	0.000845	0.00542	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—RELN—schizophrenia	0.000826	0.0053	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GCLM—schizophrenia	0.00082	0.00527	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—YWHAZ—schizophrenia	0.000795	0.00511	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PIK3C2A—schizophrenia	0.000775	0.00498	CbGpPWpGaD
Rasagiline—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—schizophrenia	0.000769	0.00494	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—GSK3B—schizophrenia	0.000766	0.00492	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—FOS—schizophrenia	0.000761	0.00489	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—schizophrenia	0.000742	0.00477	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—FOS—schizophrenia	0.000732	0.0047	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—HSPA1A—schizophrenia	0.000721	0.00463	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.000704	0.00452	CbGpPWpGaD
Rasagiline—BCL2—Activation of BAD and translocation to mitochondria—AKT1—schizophrenia	0.000668	0.00429	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TP53—schizophrenia	0.000654	0.0042	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—FOS—schizophrenia	0.000647	0.00415	CbGpPWpGaD
Rasagiline—CYP1A2—Xenobiotics—CYP2D6—schizophrenia	0.000643	0.00413	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—GSK3B—schizophrenia	0.000631	0.00405	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—ESR1—schizophrenia	0.000619	0.00397	CbGpPWpGaD
Rasagiline—CYP1A2—Tamoxifen metabolism—CYP2D6—schizophrenia	0.000619	0.00397	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—CLOCK—schizophrenia	0.000613	0.00394	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—GSK3B—schizophrenia	0.000603	0.00387	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—FOS—schizophrenia	0.000599	0.00384	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—GSTM1—schizophrenia	0.000594	0.00381	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—schizophrenia	0.000578	0.00371	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—FOS—schizophrenia	0.000558	0.00358	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—FOS—schizophrenia	0.000558	0.00358	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—TPH1—schizophrenia	0.000545	0.0035	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen metabolism—COMT—schizophrenia	0.00053	0.00341	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—schizophrenia	0.000525	0.00337	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—HSPA1A—schizophrenia	0.000511	0.00328	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP2D6—schizophrenia	0.000497	0.00319	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.000495	0.00318	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—ESR1—schizophrenia	0.000494	0.00317	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.000488	0.00313	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen metabolism—GSTM1—schizophrenia	0.000485	0.00311	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—SOD2—schizophrenia	0.000484	0.00311	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—CYP2D6—schizophrenia	0.000478	0.00307	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—schizophrenia	0.000477	0.00306	CbGpPWpGaD
Rasagiline—BCL2—Estrogen signaling pathway—AKT1—schizophrenia	0.000474	0.00305	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP1A2—schizophrenia	0.00045	0.00289	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—AKT1—schizophrenia	0.000444	0.00285	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—schizophrenia	0.000426	0.00274	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.000401	0.00257	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—schizophrenia	0.000396	0.00255	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—FOS—schizophrenia	0.000394	0.00253	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—schizophrenia	0.000393	0.00253	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—GSK3B—schizophrenia	0.000393	0.00253	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—FOS—schizophrenia	0.000391	0.00251	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—COMT—schizophrenia	0.000377	0.00242	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—schizophrenia	0.000376	0.00241	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—schizophrenia	0.000376	0.00241	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTP1—schizophrenia	0.000375	0.00241	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—MAOA—schizophrenia	0.000374	0.0024	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—EP300—schizophrenia	0.000369	0.00237	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—EP300—schizophrenia	0.000369	0.00237	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NPEPPS—schizophrenia	0.000361	0.00232	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—MAOA—schizophrenia	0.00036	0.00231	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—GSK3B—schizophrenia	0.000354	0.00227	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—schizophrenia	0.000354	0.00227	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—EP300—schizophrenia	0.00035	0.00225	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTM1—schizophrenia	0.000345	0.00221	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—GSK3B—schizophrenia	0.000344	0.00221	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—YWHAZ—schizophrenia	0.000342	0.0022	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—schizophrenia	0.000334	0.00215	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GCLM—schizophrenia	0.000325	0.00208	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—AKT1—schizophrenia	0.000324	0.00208	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.000322	0.00207	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PRODH—schizophrenia	0.000322	0.00207	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—AKT1—schizophrenia	0.000317	0.00204	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.000317	0.00204	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—schizophrenia	0.000308	0.00198	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.000308	0.00198	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—NDST3—schizophrenia	0.000307	0.00197	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—AKT1—schizophrenia	0.000305	0.00196	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	0.0003	0.00193	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—AKT1—schizophrenia	0.000293	0.00188	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.000292	0.00187	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—AKT1—schizophrenia	0.000282	0.00181	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—AKT1—schizophrenia	0.000282	0.00181	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—EP300—schizophrenia	0.000278	0.00179	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—APOE—schizophrenia	0.000273	0.00175	CbGpPWpGaD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.000267	0.00172	CbGpPWpGaD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.000264	0.00169	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NRG3—schizophrenia	0.000263	0.00169	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—AKT1—schizophrenia	0.000263	0.00169	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MPC2—schizophrenia	0.000263	0.00169	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—schizophrenia	0.000261	0.00167	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—AKT1—schizophrenia	0.000259	0.00166	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—schizophrenia	0.000251	0.00161	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLCH2—schizophrenia	0.000244	0.00157	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.000242	0.00155	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—GSK3B—schizophrenia	0.000236	0.00152	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NDST3—schizophrenia	0.00023	0.00147	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—AKT1—schizophrenia	0.000229	0.00147	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—schizophrenia	0.000226	0.00145	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—AKT1—schizophrenia	0.000223	0.00143	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—GSK3B—schizophrenia	0.00022	0.00141	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SLC27A5—schizophrenia	0.000218	0.0014	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ACSL6—schizophrenia	0.000218	0.0014	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.000217	0.00139	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PLA2G4A—schizophrenia	0.000214	0.00138	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP26B1—schizophrenia	0.000213	0.00137	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP26B1—schizophrenia	0.00021	0.00135	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—DAO—schizophrenia	0.000208	0.00133	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—schizophrenia	0.000199	0.00128	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PNP—schizophrenia	0.000199	0.00128	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GCLM—schizophrenia	0.00019	0.00122	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—schizophrenia	0.000187	0.0012	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NDUFV2—schizophrenia	0.000185	0.00119	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—EP300—schizophrenia	0.000185	0.00119	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—schizophrenia	0.00018	0.00116	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.000174	0.00112	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIP4K2A—schizophrenia	0.000174	0.00112	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HLA-E—schizophrenia	0.00017	0.00109	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—schizophrenia	0.000168	0.00108	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—schizophrenia	0.000167	0.00107	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.000163	0.00105	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—schizophrenia	0.000162	0.00104	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP26B1—schizophrenia	0.000157	0.00101	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL3RA—schizophrenia	0.000157	0.00101	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—schizophrenia	0.000156	0.001	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NRG3—schizophrenia	0.000153	0.000985	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—COMT—schizophrenia	0.000149	0.000957	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTP1—schizophrenia	0.000148	0.000952	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.000144	0.000927	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—S100B—schizophrenia	0.000141	0.000908	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCLM—schizophrenia	0.00014	0.000901	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TPH1—schizophrenia	0.00014	0.000901	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—schizophrenia	0.000138	0.000889	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—schizophrenia	0.000137	0.000877	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTM1—schizophrenia	0.000136	0.000875	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB4—schizophrenia	0.000135	0.000868	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CAMK2B—schizophrenia	0.000134	0.000858	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—schizophrenia	0.000132	0.00085	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PRKD1—schizophrenia	0.000132	0.000847	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NRG1—schizophrenia	0.000125	0.000801	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.000125	0.0008	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MEF2C—schizophrenia	0.000124	0.000794	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NCAM1—schizophrenia	0.000122	0.000785	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—schizophrenia	0.000122	0.000784	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—schizophrenia	0.00012	0.000771	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.000117	0.000752	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB3—schizophrenia	0.000117	0.00075	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—CYP2D6—schizophrenia	0.000115	0.000739	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP2D6—schizophrenia	0.000113	0.000728	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.000113	0.000726	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.000113	0.000726	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GAPDH—schizophrenia	0.00011	0.000707	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CLOCK—schizophrenia	0.000109	0.000701	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—schizophrenia	0.000107	0.000689	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—schizophrenia	0.000107	0.000689	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TPH2—schizophrenia	0.000106	0.000683	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CACNB2—schizophrenia	0.000106	0.000683	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000105	0.000676	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—DPYD—schizophrenia	0.000105	0.000672	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.000103	0.000663	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—schizophrenia	0.000103	0.000662	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-E—schizophrenia	9.88e-05	0.000635	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CACNA1C—schizophrenia	9.72e-05	0.000624	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PIK3C2A—schizophrenia	9.48e-05	0.000609	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—GSK3B—schizophrenia	9.06e-05	0.000582	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	9.04e-05	0.000581	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—FOS—schizophrenia	9e-05	0.000578	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRL—schizophrenia	8.83e-05	0.000567	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—AKT1—schizophrenia	8.76e-05	0.000562	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	8.72e-05	0.00056	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—COMT—schizophrenia	8.72e-05	0.00056	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—schizophrenia	8.72e-05	0.00056	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—schizophrenia	8.72e-05	0.00056	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTP1—schizophrenia	8.68e-05	0.000557	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—MAOA—schizophrenia	8.66e-05	0.000556	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—COMT—schizophrenia	8.6e-05	0.000552	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTP1—schizophrenia	8.56e-05	0.000549	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—SNAP25—schizophrenia	8.5e-05	0.000546	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP2D6—schizophrenia	8.5e-05	0.000546	CbGpPWpGaD
Rasagiline—BCL2—Immune System—S100B—schizophrenia	8.23e-05	0.000529	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTM1—schizophrenia	7.97e-05	0.000512	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB4—schizophrenia	7.87e-05	0.000506	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTM1—schizophrenia	7.86e-05	0.000505	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1A2—schizophrenia	7.69e-05	0.000494	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—TH—schizophrenia	7.58e-05	0.000486	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PRODH—schizophrenia	7.46e-05	0.000479	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NRG1—schizophrenia	7.27e-05	0.000467	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MEF2C—schizophrenia	7.2e-05	0.000462	CbGpPWpGaD
Rasagiline—BCL2—Immune System—YWHAZ—schizophrenia	6.96e-05	0.000447	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	6.85e-05	0.00044	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ERBB3—schizophrenia	6.81e-05	0.000437	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—COMT—schizophrenia	6.44e-05	0.000414	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTP1—schizophrenia	6.41e-05	0.000412	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MAOA—schizophrenia	6.4e-05	0.000411	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MPC2—schizophrenia	6.08e-05	0.00039	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ABCB1—schizophrenia	6.07e-05	0.00039	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EP300—schizophrenia	5.96e-05	0.000383	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLA2G4A—schizophrenia	5.89e-05	0.000378	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTM1—schizophrenia	5.89e-05	0.000378	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	5.67e-05	0.000364	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLCH2—schizophrenia	5.65e-05	0.000363	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NDST3—schizophrenia	5.32e-05	0.000341	CbGpPWpGaD
Rasagiline—BCL2—Immune System—GSK3B—schizophrenia	5.27e-05	0.000339	CbGpPWpGaD
Rasagiline—BCL2—Immune System—FOS—schizophrenia	5.24e-05	0.000337	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—MTHFR—schizophrenia	5.21e-05	0.000334	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC27A5—schizophrenia	5.04e-05	0.000324	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ACSL6—schizophrenia	5.04e-05	0.000324	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	4.92e-05	0.000316	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOE—schizophrenia	4.85e-05	0.000311	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DAO—schizophrenia	4.81e-05	0.000309	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—APOA1—schizophrenia	4.79e-05	0.000308	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PNP—schizophrenia	4.61e-05	0.000296	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NDUFV2—schizophrenia	4.28e-05	0.000275	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIP4K2A—schizophrenia	4.03e-05	0.000259	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—schizophrenia	3.88e-05	0.000249	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP26B1—schizophrenia	3.64e-05	0.000234	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—AKT1—schizophrenia	3.6e-05	0.000231	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EP300—schizophrenia	3.47e-05	0.000223	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TPH1—schizophrenia	3.25e-05	0.000208	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCLM—schizophrenia	3.25e-05	0.000208	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	3.06e-05	0.000197	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PRKD1—schizophrenia	3.05e-05	0.000196	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—EP300—schizophrenia	2.76e-05	0.000177	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GAPDH—schizophrenia	2.55e-05	0.000164	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CLOCK—schizophrenia	2.52e-05	0.000162	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.52e-05	0.000162	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.49e-05	0.00016	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TPH2—schizophrenia	2.46e-05	0.000158	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CACNB2—schizophrenia	2.46e-05	0.000158	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—DPYD—schizophrenia	2.42e-05	0.000155	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CACNA1C—schizophrenia	2.25e-05	0.000145	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PIK3C2A—schizophrenia	2.19e-05	0.000141	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—schizophrenia	2.1e-05	0.000135	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP2D6—schizophrenia	1.97e-05	0.000126	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SNAP25—schizophrenia	1.97e-05	0.000126	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TH—schizophrenia	1.75e-05	0.000113	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—schizophrenia	1.67e-05	0.000107	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—COMT—schizophrenia	1.49e-05	9.57e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTP1—schizophrenia	1.48e-05	9.53e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MAOA—schizophrenia	1.48e-05	9.51e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.44e-05	9.22e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCB1—schizophrenia	1.4e-05	9.02e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G4A—schizophrenia	1.36e-05	8.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTM1—schizophrenia	1.36e-05	8.76e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—MTHFR—schizophrenia	1.21e-05	7.74e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOE—schizophrenia	1.12e-05	7.2e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APOA1—schizophrenia	1.11e-05	7.12e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—EP300—schizophrenia	6.39e-06	4.11e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—schizophrenia	3.86e-06	2.48e-05	CbGpPWpGaD
